Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed Infants
NCT01222130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1126
Last updated 2014-09-18
Summary
This study is designed to develop and evaluate a set of non-virologic diagnostic algorithms to monitor HIV-exposed children of unknown infection status for treatment eligibility during the first year of life. The results of this cross sectional study are expected to be used in development of a series of non-virologic algorithms to determining treatment eligibility among HIV-exposed children in settings where polymerase chain reaction (PCR) testing is not available and to guide the judicious use of PCR testing among HIV-exposed children in settings where PCR is available. These results will directly inform program implementation in Zambia.
Conditions
- HIV Infections
Sponsors & Collaborators
-
Elizabeth Glaser Pediatric AIDS Foundation
collaborator OTHER -
University of North Carolina, Chapel Hill
lead OTHER
Eligibility
- Max Age
- 60 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- Zambia
Study Locations
More Related Trials
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe
NCT04206241 ·Status: COMPLETED
-
Impact of Point-of-Care EID for HIV-Exposed Infants
NCT03824067 ·Status: COMPLETED ·Phase: NA
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
NCT04087239 ·Status: ACTIVE_NOT_RECRUITING
-
ART Readiness in HIV-infected Pregnant Women
NCT02459678 ·Status: COMPLETED ·Phase: NA
-
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
NCT00753324 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
NCT01555723 ·Status: WITHDRAWN
-
A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
NCT00000952 ·Status: COMPLETED ·Phase: PHASE1
-
Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP
NCT00204308 ·Status: COMPLETED ·Phase: PHASE2
-
Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi
NCT06506188 ·Status: RECRUITING ·Phase: NA
-
Immune Function of Infants With HIV
NCT00073229 ·Status: COMPLETED
-
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000750 ·Status: COMPLETED ·Phase: PHASE3
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth
NCT00001007 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.
NCT00000855 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
NCT06517693 ·Status: RECRUITING ·Phase: PHASE1
-
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV
NCT01433185 ·Status: COMPLETED ·Phase: NA
-
Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
NCT01645865 ·Status: COMPLETED
-
HIV Exposure in Utero and Metabolic Disease Risk in HIV-Negative Young Adults
NCT04132830 ·Status: COMPLETED
-
Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
NCT00000828 ·Status: COMPLETED
-
Antiretroviral Regime for Viral Eradication in Newborns
NCT02712801 ·Status: COMPLETED ·Phase: PHASE4
-
Preventing Unplanned Pregnancies in HIV Infected Zambian Couples
NCT00067522 ·Status: UNKNOWN ·Phase: NA
-
Becoming HIV-Exposed, Uninfected Children Born to HIV-Positive Mothers Followed at Bichat Claude Bernard Hospital
NCT06666543 ·Status: COMPLETED